Radiopharmaceutical Manufacturing and Supply – POSLUMA F18 rhPSMA

The contract entails the manufacture and delivery of POSLUMA, a fluorine-18 labeled rhPSMA radiopharmaceutical, for use in PET CT imaging, with strict adherence to current Good Manufacturing Practices and all applicable regulatory standards to ensure consistent product quality and safety. The work requires full compliance with radiopharmaceutical production protocols, including rigorous quality control measures, batch documentation, and validation procedures to meet federal and industry requirements for clinical application. The subcontractor must ensure timely, reliable supply of the tracer to support diagnostic imaging services, maintaining stability and potency through controlled logistics and handling. Performance is centered in Little Rock, with an expected delivery timeline aligned to the response deadline of August 21, 2026, and the solicitation issued under the NAICS code 325412 for pharmaceutical preparation manufacturing. The contract is administered by the Department of Veterans Affairs through the 256-NETWORK Contract Office 16, and the award is intended to secure a dependable source of this specialized diagnostic agent to meet the needs of VA medical facilities. All aspects of production, packaging, labeling, and transportation must comply with FDA and NRC regulations, supporting the ongoing integration of advanced molecular imaging into veteran healthcare.